CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  About Us  /  Board of Directors  /  Daniel M. Bradbury

Daniel M. Bradbury

Independent and Non-Executive Director

Daniel M. Bradbury - Biocon

Daniel M. Bradbury

Independent and Non-Executive Director

Member of the Board of Directors since 2013
Year of birth: 1961

Professional Experience

  • Executive Chairman, former CEO and Co-Founder of Equillium Inc., a company developing products to treat severe autoimmune and inflammatory disorders
  • Managing Member, BioBrit LLC
  • Member, Board of Trustees, Keck Graduate Institute, U.S.
  • Member, Advisory Council, Rady School of Management, San Diego, U.S.
  • Life sciences executive with over 37 years of experience in creating and implementing strategies and transforming businesses
  • Former CEO, Amylin Pharmaceuticals, a leading metabolic disease company, acquired by Bristol Myers Squibb in 2012

Recognitions

  • Recipient of Director of the Year Award from Corporate Directors Forum (2012)
  • EY’s Entrepreneur of the Year Finalist (2012)

Education

  • International Executive Program, INSEAD, France
  • Diploma in Management Studies, Harrow and Ealing Colleges of Higher Education, UK
  • Bachelor of Pharmacy, Nottingham University, UK
Share